Veeva Systems announced details of 2019 Veeva Quality & Regulatory Global Summit. The event will be held on October 8, 2019 in Chicago and will feature industry experts from leading companies, including a keynote panel with Colgate-Palmolive, and Unilever, sharing best practices to improve speed and agility across the product lifecycle.
The one-day educational event will offer more than 14 sessions with industry experts and top consumer goods, chemical, and cosmetics companies, including:
• The Personal Care Products Council (PCPC) and Cosmetics Alliance Canada (CAC) discussing regulatory implications of global markets and supply chains.
• Web Industries and Unilever highlighting best practices to drive greater transparency and collaboration across stakeholders.
• Accenture on building a business case to move from paper and legacy systems to the cloud.
Participants can attend quality and regulatory tracks for in-depth sessions on how to use quality and regulatory data to make smarter decisions, drive quality across supplier networks, and better manage convergence in global regulatory requirements across industries.
The Veeva Quality & Regulatory Summit brings together senior quality, regulatory, and IT professionals in regulated industries. The event is complimentary for Veeva customers and invited guests. Learn more, register, and view the full agenda at industries.veeva.com/GlobalSummit.
About Veeva Systems
Founded in 2007, Veeva Systems (veeva.com) is a global provider of cloud-based software solutions. We help quality, regulatory, and commercial teams in the cosmetics, consumer goods, and chemical industries unify disconnected processes, documents, and data. In doing so, we help our customers eliminate inefficiencies so they can bring innovative, high quality products to market faster without compromising compliance. Veeva is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America.
This release contains forward-looking statements, including the market demand for and acceptance of Veeva’s products and services, the results from use of Veeva’s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions,“Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in the company’s filing on Form 10-Q for the period ended July 31, 2019. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.